First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.
We report the first case in Ireland of an IMI-1 carbapenemase-producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.
Department of Medical Microbiology, Galway University Hospitals, HSE West, Ireland. teck.boo@hse.ie
T W
TW
Boo
N
N
O'Connell
L
L
Power
M
M
O'Connor
J
J
King
E
E
McGrath
R
R
Hill
K L
KL
Hopkins
N
N
Woodford
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003091:Colistin / Q000494:pharmacology* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D004754:Enterobacter / Q000187:drug effects* / Q000302:isolation & purification*; D005260:Female; D005578:Fosfomycin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007494:Ireland; D008297:Male; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D003091:Colistin